Recruiting studies: Short Course Radiotherapy Plus Chemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer
Phase 2 · 1 location(s) · Fudan University · NCT06455124 Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04703101 SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Ca
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT06864013 Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab a
Phase 2 · 1 location(s) · Dechang Diao · NCT07005570 A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
Phase 2 · 1 location(s) · First Affiliated Hospital of Wenzhou Medical University · NCT07347951 SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT06850103 Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer
Phase 2 · 1 location(s) · fan li · NCT06718543 Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MO
Phase 2/Phase 3 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06958432 A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
EARLY_Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05691010 Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorect
Phase 2/Phase 3 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06958419 Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced
Phase 2 · 1 location(s) · Renmin Hospital of Wuhan University · NCT05563012 Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locall
Phase 2 · 1 location(s) · Feng Tian · NCT06765616 Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advance
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07594925 A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunoth
Phase 2 · 1 location(s) · Tao Zhang · NCT07239466 Neoadjuvant Short-course Hypofractionated Radiotherapy Plus Adebrelimab and Platinum Chemotherapy in Locally Advanced Ce
Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07731828 A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemot
Phase 2 · 3 location(s) · Weill Medical College of Cornell University · NCT05024097 Nodal-Region Sparing Short-Course RT With Chemo-PD-1/Bevacizumab vs. Short-Course RT With Chemotherapy as TNT in pMMR/MS
Phase 2 · 1 location(s) · Dechang Diao · NCT07674732 SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
Phase 2 · 1 location(s) · Huazhong University of Science and Technology · NCT06516445 Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit
Phase 2/Phase 3 · 1 location(s) · The First Hospital of Jilin University · NCT07505472 SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
Phase 3 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07549399

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.